Our News - Care 4 Quality

Class 4 Medicines Defect Information, Amoxicillin 500 mg/ 5 ml Powder for oral suspension, (PL 25298/0248), EL (21)A/18

July 20, 2021

Brown & Burk UK Limited have noticed an error regarding specific batches of Amoxicillin 500 mg/ 5 ml Powder for oral suspension. The product information incorrectly states the quantity of the excipient sodium benzoate. PL […]

Continue Reading

Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets, (PL 16950/0063, PL 16950/0064), EL (21)A/17

July 15, 2021

Napp Pharmaceuticals Limited have noticed and an error in the PIL of specific batches of Sevredol 10 mg Tablets and Sevredol 20 mg Tablets. PL Number(s) PL 16950/0063, PL 16950/0064 MDR Number MDR 074-07/21 Company […]

Continue Reading

Vein Solutions Ltd Are Now Registered with the CQC

July 8, 2021

One of our clients, Vein Solutions Ltd, are now successfully registered with the CQC. They are a multi-speciality vascular treatment clinic based in Cheshire, who offer a comprehensive range of varicose vein treatment options, encompassing […]

Continue Reading

Class 4 Medicines Defect Information, Tetralysal 300mg Hard Capsules, (PL 10590/0019), EL (21)A/16

July 7, 2021

Galderma UK identified an error regarding an older version of artwork being used and packed with specific batches of Tetralysal 300mg Hard Capsules. PL Number(s) PL 10590/0019 MDR Number MDR 387-06/21 Company Name Galderma UK […]

Continue Reading

Company led medicines recall: Morphine Syringe 50mg/50ml (unlicensed medicine) and Magnesium Sulphate 8mmol/20ml infusion (unlicensed medicine)

July 1, 2021

CLMR Number CLMR (21)A/05 MDR Number MDR 377-06/21 Company Name Nova Laboratories Limited (MS 13581) Product description Morphine Syringe 50mg/50ml (unlicensed medicine) Magnesium Sulphate 8mmol/20ml infusion (unlicensed medicine) Lot Number/Expiry Product name Batch Number Expiry […]

Continue Reading

NEW! Equality & Diversity Audit Tool (Includes AIS – Accessible Information Standard) £10.99

July 1, 2021

In May 2021 CQC released guidance around culturally appropriate care. We have designed an Equality & Diversity Audit which covers the key themes of this guidance and blended this with requirements around accessible information standards […]

Continue Reading

Why the CQC’s Equality Objectives are Important to Healthcare Providers

June 30, 2021

By CQC Inspections Lead, Gabi Ashton In April 2019, the CQC launched their Equality Objectives for 2019-21. As it is currently pride month, I on behalf of Care 4 Quality., want to highlight the […]

Continue Reading

Care 4 Quality. Acquired by Employment Law Specialists, Ellis Whittam

June 30, 2021

The leadership team at Care 4 Quality. are delighted to announce that we have been acquired by Marlowe plc to join the Ellis Whittam family. After a successful three years in the compliance space, we’re […]

Continue Reading

CQC Plans to Carry Out Monthly Online Checks on GP Practices

June 21, 2021

In a statement published by CQC Chief Inspectors, the regulator has announced they are planning to carry out online remote checks on GP practices ‘every month’ to assess risk to patients. Once the check has […]

Continue Reading

Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14

June 17, 2021

Specific batches of products supplied by Bristol Laboratories Limited, Brown & Burk UK Limited and Teva UK Limited are being recalled due to presence of a mutagenic impurity. Company name Bristol Laboratories Limited Irbesartan 75 […]

Continue Reading

MHRA Drug Recall Alert Recall Of Co-Codamol 30/500 Effervescent Tablets, Batch 1k10121, Zentiva Pharma Uk Ltd

June 16, 2021

Recall of Co-codamol 30/500 Effervescent Tablets, Batch 1K10121, Zentiva Pharma UK Ltd due to precautionary risk of causing overdose Zentiva Pharma UK Limited have notified the MHRA of an issue related to the homogeneity of […]

Continue Reading

The Women’s Hormone Clinic is Now Registered with the Care Quality Commission

June 15, 2021

One of our clients, The Women’s Hormone Clinic is now successfully registered with the CQC. The clinic is a private practice specialising in menopause and pre-menopause care. Dr Rebecca Poet is a sole trader GP […]

Continue Reading

The Importance of Using Person-Centred Language in Long-Term Care Facilities

June 4, 2021

Person-centred language contributes to a feeling of positive, person-centred culture across care services. You may not think it, but using particular language changes the way people think about themselves and can determine whether or not […]

Continue Reading

New Product: Care Staff Induction Booklet

June 2, 2021

This Induction Booklet is designed to support in the Induction of Care Workers who are joining your team. The document will be available to download as a Word (editable) document. Regulation 18 of the Health […]

Continue Reading

Medicines Recall Alert: Class 3 Medicines Recall: Advanz Pharma, Carbimazole 10mg and 15mg tablets, EL (21)A/13

May 28, 2021

Advanz Pharma is recalling batches of carbimazole tablets due to an out of specification observation for tablet appearance of samples during routine stability testing. PL Number(s) PL 20072/0244 PL 20072/0245 MDR Number MDR 359-04/21 Company […]

Due to ongoing changes in the CQC registration process, our Registration Support service is temporarily unavailable.
Please register your interest to receive updates on when it will resume.

Class 4 Medicines Defect Information, Amoxicillin 500 mg/ 5 ml Powder for oral suspension, (PL 25298/0248), EL (21)A/18

Continue Reading

Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets, (PL 16950/0063, PL 16950/0064), EL (21)A/17

Continue Reading

Vein Solutions Ltd Are Now Registered with the CQC

Continue Reading

Class 4 Medicines Defect Information, Tetralysal 300mg Hard Capsules, (PL 10590/0019), EL (21)A/16

Continue Reading

Company led medicines recall: Morphine Syringe 50mg/50ml (unlicensed medicine) and Magnesium Sulphate 8mmol/20ml infusion (unlicensed medicine)

Continue Reading

NEW! Equality & Diversity Audit Tool (Includes AIS – Accessible Information Standard) £10.99

Continue Reading

Why the CQC’s Equality Objectives are Important to Healthcare Providers

Continue Reading

Care 4 Quality. Acquired by Employment Law Specialists, Ellis Whittam

Continue Reading

CQC Plans to Carry Out Monthly Online Checks on GP Practices

Continue Reading

Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14

Continue Reading

MHRA Drug Recall Alert Recall Of Co-Codamol 30/500 Effervescent Tablets, Batch 1k10121, Zentiva Pharma Uk Ltd

Continue Reading

The Women’s Hormone Clinic is Now Registered with the Care Quality Commission

Continue Reading

The Importance of Using Person-Centred Language in Long-Term Care Facilities

Continue Reading

New Product: Care Staff Induction Booklet

Continue Reading

Medicines Recall Alert: Class 3 Medicines Recall: Advanz Pharma, Carbimazole 10mg and 15mg tablets, EL (21)A/13

Continue Reading

Request a Callback with Our Specialist Team!

CONTACT US

Care 4 Quality Ltd.

CARE HOME SERVICES & PRICING

TRAINING COURSES

LEGAL